Ayodeji Ige

Ayodeji Ige

Auto-generated profile, based on publicly available information

Ayodeji Ige

University of Ilorin

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2026 in African Journal of Nutrition and Dietetics
Verified
Journal Article
Open access
AIAyodeji Ige
Ayodeji Ige
OOOluwasola Michael Ojo
Oluwasola Michael Ojo
KDKelly Taiwo Demehin
Kelly Taiwo Demehin
INInnocent Maduabuchukwu Nkollo
Innocent Maduabuchukwu Nkollo
Monosodium glutamate (MSG), a widely used flavor enhancer, is linked to metabolic and ocular complications, potentially increasing cataract risk. This study evaluated spectral transmission in lens tissue of MSG-induced hyperglycemic male Wistar rats to assess optical changes. Ten male Wistar rats were randomly assigned to control (distilled water) or experimental (750 mg/kg MSG daily for 28 days) groups (n = 5 each) using a random number table. Body weight and blood glucose were monitored. Lenses were extracted on day 36, homogenized, and analyzed for spectral transmission (250–700 nm) using UV-Visible spectrophotometry. Data were analyzed with ANOVA test (p < 0.05) in GraphPad Prism. MSG-treated rats showed significant weight gain (p < 0.05) and hyperglycemia (p < 0.05) compared to controls. Lens transmittance was reduced (p = 0.053), and absorbance was increased (p = 0.145), suggesting protein aggregation. Chronic MSG exposure induces metabolic stress and may impair lens clarity in rats, potentially linked to cataract risk. Further studies on oxidative biomarkers are needed to confirm MSG’s ocular toxicity, specifically by quantifying lens- specific oxidative stress markers (GSH/GSSG ratio, malondialdehyde, protein carbonyl content, 8- HdG, and activities of SOD, CAT, GPx).

25 September 2026 in The EYE GLAZ
Verified
Journal Article
Closed access
PDF file
AIA. E. Ige
A. E. Ige
OOOluwasola Michael Ojo
Oluwasola Michael Ojo
AIA. Idris
A. Idris
MNM. I. Nkollo
M. I. Nkollo
АИА. Э. Идж
А. Э. Идж
МНМ. И. Нколло
М. И. Нколло
   Background. Glaucoma is a major public health concern, accounting for 8% of blindness worldwide and 16.7 % of blindness in Nigeria. Early diagnosis and reduction of intraocular pressure (IOP) are critical for preventing optic nerve damage. Although topical medications are generally used as initial therapy, uncontrolled IOP may require surgical intervention. Laser peripheral iridotomy (LPI) is a standard procedure for primary angle-closure glaucoma (PACG) that relieves pupillary block, lowers IOP, and reduces the risk of vision loss.    Purpose. To evaluate changes in IOP following Nd:YAG laser peripheral iridotomy in patients with PACG.    Materials and methods. A retrospective analysis of 104 medical records of patients with PACG treated at the Makkah Specialist Eye Hospital in Kano, Nigeria, from January 2020 to December 2024, was conducted. Included were patients aged 31–80 years, with IOP measurements before and after LPI. Changes in IOP were evaluated using the paired t-test.    Results. In the majority of patients (54 patients, 51.9 %), the IOP level was 20–29 mm Hg, followed by the range 30–39 mm Hg (22 patients, 21.2 %), and the smallest number of patients had pressure 10–19 mm Hg (8 patients, 7.7 %). Ten patients were lost to follow-up. Among the remaining 94 patients, the majority (63 patients, 67 %) achieved IOP in the range of 10–19 mm Hg, followed by the range 20–29 mm Hg (20 patients, 21.3 %), and only 3 (3.2 %) patients had pressure remaining within 40–49 mm Hg. Mean IOP decreased significantly from 28.63 ± 9.50 mm Hg before LPI to 18.22 ± 8.54 mm Hg after LPI (t (93) = 11.30, p < 0.001).    Conclusion. In this retrospective study, YAG laser peripheral iridotomy was associated with a statistically significant mean reduction in IOP of 10.4 mm Hg in patients with PACG, supporting its role as a first-line intervention in this patient population.